Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $5.46 Million - $7.12 Million
137,600 New
137,600 $7.12 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $33.7 Million - $40.4 Million
548,500 Added 2715.35%
568,700 $41.5 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $1.72 Million - $1.95 Million
-29,800 Reduced 59.6%
20,200 $1.25 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $18.2 Million - $20.2 Million
-317,700 Reduced 86.4%
50,000 $3.02 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $25 Million - $32.6 Million
-507,400 Reduced 57.98%
367,700 $23.6 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $354,991 - $420,893
8,300 Added 0.96%
875,100 $44.4 Million
Q2 2019

Aug 12, 2019

BUY
$44.62 - $49.34 $32.2 Million - $35.6 Million
720,600 Added 492.89%
866,800 $39.3 Million
Q1 2019

May 10, 2019

SELL
$45.12 - $53.8 $17 Million - $20.2 Million
-375,800 Reduced 71.99%
146,200 $6.98 Million
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $24.7 Million - $32 Million
506,400 Added 3246.15%
522,000 $27.1 Million
Q3 2018

Nov 09, 2018

SELL
$55.19 - $62.25 $3.48 Million - $3.92 Million
-63,000 Reduced 80.15%
15,600 $968,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $4.34 Million - $5.01 Million
78,600
78,600 $5.01 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.